Logo image of AMTX

AEMETIS INC (AMTX) Stock Fundamental Analysis

NASDAQ:AMTX - Nasdaq - US00770K2024 - Common Stock - Currency: USD

2.67  +0.25 (+10.33%)

After market: 2.67 0 (0%)

Fundamental Rating

1

AMTX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 208 industry peers in the Oil, Gas & Consumable Fuels industry. AMTX has a bad profitability rating. Also its financial health evaluation is rather negative. AMTX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AMTX had negative earnings in the past year.
AMTX had a negative operating cash flow in the past year.
AMTX had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AMTX reported negative operating cash flow in multiple years.
AMTX Yearly Net Income VS EBIT VS OCF VS FCFAMTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

AMTX has a Return On Assets of -36.22%. This is amonst the worse of the industry: AMTX underperforms 93.75% of its industry peers.
Industry RankSector Rank
ROA -36.22%
ROE N/A
ROIC N/A
ROA(3y)-34.96%
ROA(5y)-32.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMTX Yearly ROA, ROE, ROICAMTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

1.3 Margins

AMTX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMTX Yearly Profit, Operating, Gross MarginsAMTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

More info and screens

0

2. Health

2.1 Basic Checks

AMTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMTX has been increased compared to 1 year ago.
AMTX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMTX has a worse debt to assets ratio.
AMTX Yearly Shares OutstandingAMTX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AMTX Yearly Total Debt VS Total AssetsAMTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -3.61, we must say that AMTX is in the distress zone and has some risk of bankruptcy.
AMTX's Altman-Z score of -3.61 is on the low side compared to the rest of the industry. AMTX is outperformed by 76.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.61
ROIC/WACCN/A
WACC5.22%
AMTX Yearly LT Debt VS Equity VS FCFAMTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

A Current Ratio of 0.16 indicates that AMTX may have some problems paying its short term obligations.
The Current ratio of AMTX (0.16) is worse than 96.15% of its industry peers.
AMTX has a Quick Ratio of 0.16. This is a bad value and indicates that AMTX is not financially healthy enough and could expect problems in meeting its short term obligations.
AMTX has a Quick ratio of 0.03. This is amonst the worse of the industry: AMTX underperforms 96.63% of its industry peers.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.03
AMTX Yearly Current Assets VS Current LiabilitesAMTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for AMTX have decreased strongly by -40.87% in the last year.
Looking at the last year, AMTX shows a very strong growth in Revenue. The Revenue has grown by 43.34%.
The Revenue has been growing slightly by 5.79% on average over the past years.
EPS 1Y (TTM)-40.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.88%
Revenue 1Y (TTM)43.34%
Revenue growth 3Y8.1%
Revenue growth 5Y5.79%
Sales Q2Q%-21.52%

3.2 Future

Based on estimates for the next years, AMTX will show a very strong growth in Earnings Per Share. The EPS will grow by 33.11% on average per year.
The Revenue is expected to grow by 32.55% on average over the next years. This is a very strong growth
EPS Next Y36.95%
EPS Next 2Y37.77%
EPS Next 3Y34.08%
EPS Next 5Y33.11%
Revenue Next Year12.51%
Revenue Next 2Y46.8%
Revenue Next 3Y43.3%
Revenue Next 5Y32.55%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMTX Yearly Revenue VS EstimatesAMTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B
AMTX Yearly EPS VS EstimatesAMTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AMTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AMTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMTX Price Earnings VS Forward Price EarningsAMTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMTX Per share dataAMTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as AMTX's earnings are expected to grow with 34.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.77%
EPS Next 3Y34.08%

More info and screens

0

5. Dividend

5.1 Amount

AMTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AEMETIS INC

NASDAQ:AMTX (8/8/2025, 8:19:02 PM)

After market: 2.67 0 (0%)

2.67

+0.25 (+10.33%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-10 2025-11-10/amc
Inst Owners20.97%
Inst Owner Change1.52%
Ins Owners8.42%
Ins Owner Change4.51%
Market Cap147.84M
Analysts78.18
Price Target11.53 (331.84%)
Short Float %9.03%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.73%
Min EPS beat(2)-9.54%
Max EPS beat(2)13%
EPS beat(4)2
Avg EPS beat(4)-8.54%
Min EPS beat(4)-49.09%
Max EPS beat(4)13%
EPS beat(8)3
Avg EPS beat(8)16.82%
EPS beat(12)4
Avg EPS beat(12)-2.87%
EPS beat(16)6
Avg EPS beat(16)-0.47%
Revenue beat(2)0
Avg Revenue beat(2)-34.62%
Min Revenue beat(2)-40.58%
Max Revenue beat(2)-28.67%
Revenue beat(4)1
Avg Revenue beat(4)-18.83%
Min Revenue beat(4)-40.58%
Max Revenue beat(4)5.4%
Revenue beat(8)1
Avg Revenue beat(8)-15.84%
Revenue beat(12)3
Avg Revenue beat(12)-18.2%
Revenue beat(16)4
Avg Revenue beat(16)-14.49%
PT rev (1m)5.26%
PT rev (3m)4.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.03%
EPS NY rev (1m)0%
EPS NY rev (3m)8.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.98%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-4.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.62
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.74
FCFYN/A
OCF(TTM)-0.41
OCFYN/A
SpS4.3
BVpS-5.07
TBVpS-5.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.22%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-34.96%
ROA(5y)-32.7%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 206.75%
Cap/Sales 7.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.03
Altman-Z -3.61
F-Score2
WACC5.22%
ROIC/WACCN/A
Cap/Depr(3y)471.61%
Cap/Depr(5y)458.17%
Cap/Sales(3y)13.52%
Cap/Sales(5y)12.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.88%
EPS Next Y36.95%
EPS Next 2Y37.77%
EPS Next 3Y34.08%
EPS Next 5Y33.11%
Revenue 1Y (TTM)43.34%
Revenue growth 3Y8.1%
Revenue growth 5Y5.79%
Sales Q2Q%-21.52%
Revenue Next Year12.51%
Revenue Next 2Y46.8%
Revenue Next 3Y43.3%
Revenue Next 5Y32.55%
EBIT growth 1Y-33.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.56%
EBIT Next 3Y90.22%
EBIT Next 5Y68.13%
FCF growth 1Y35.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.43%
OCF growth 3YN/A
OCF growth 5YN/A